Survival analytic models were used to determine the effects of Axis n pathology and dysfunctional cognitions on depressive relapse in a sample of 50 depressed inpatients followed 33 to 84 months (M = 49.9) postdischarge. In analyses based on follow-up interview measures, expected remission duration among patients without personality disorders was approximately 7.4 times longer than among patients with Axis n comorbidity. Attributional style also accounted for unique variance in the relapse model, with adaptive positive event attributions inversely related to relapse probability. Neither dysfunctional attitudes nor negative event attributions were significantly related to relapse. Dimensional Axis II Cluster B and C pathology ratings were associated with decreased survival time, whereas Cluster A pathology was associated with increased survival. Among measures obtained during index hospitalization, only the dimensional rating of Axis II pathology was significantly predictive, with a cumulative 8% decrease in expected survival for each Axis n criterion item met Depression relapse has become a primary focus of affective disorders research over the past decade, as it has become increasingly clear that a large proportion of successfully treated depressed individuals relapse within several months of clinical remission (Klerman & Weissman, 1992) . For example, by 12 months postremission between 35% and 55% of formerly depressed patients experience a relapse episode (see Belsher & Costello, 1988) . The consistent finding of such heightened relapse risk has helped catalyze research efforts to discover patient characteristics that render certain individuals especially vulnerable to relapse. The identification of such characteristics could serve to illuminate likely mechanisms through which the relapse process occurs, as well as to identify those patients for whom prophylactic treatment is most needed.
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Correspondence concerning this article should be addressed to Stephen S. Ilardi, Department of Psychology, Campus Box 345, University of Colorado, Boulder, Colorado 80309-0345. dale, 1978) of depression propose the existence of a specific cognitive diathesis to depression. This hypothesized cognitive vulnerability applies both to the initial onset of the depressive syndrome and to subsequent experiences of relapse. Interestingly, in several longitudinal tests of Beck's cognitive model, there has been little empirical support for the hypothesized relationship between depressotypic cognitions and the initial onset of depression (see Haaga, Dyck, & Ernst, 1991) ; the evidence, however, regarding a cognitive vulnerability to depressive relapse is more compelling. In fact, there have been four reported investigations of the relationship between dysfunctional attitudes-negativistic beliefs hypothesized by Beck (1976) to be depressogenic-and subsequent depressive relapse (Rush, Weissenburger, & Eaves, 1986; Segal, Shaw, Vella, & Katz, 1992; Simons, Murphy, Levine, & Wetzel, 1986; Thase et al., 1992) , each of which found a significant relapse risk associated with elevations on the Dysfunctional Attitudes Scale (DAS; Weissman & Beck, 1978) .
The reformulated learned helplessness model hypothesizes that a person's explanatory style-specifically, the tendency to attribute negative events to internal, stable, and global causesmay serve as a cognitive diathesis for depression. In a subsequent extension of the model, Seligrnan, Abramson, Semmel, and von Baeyer (1979) suggested that a characteristic style of external, specific, and unstable attributions for positive events may also prove to be depressogenic. The reformulated learned helplessness model, however, has received little empirical support vis-a-vis the prediction of depression relapse. This may be due, in part, to the surprisingly small number of studies that have reported data on attributional style in clinically depressed patient samples (see Robins & Hayes, 1995) . Alloy, Lipman, and Abramson (1992) found that a depressive attributional style among nondepressed college students was associated with a greater likelihood of such students having experienced prior depressive episodes (retrospectively assessed), many of which, presumably, were relapse episodes (although the ratio of relapses to first-onset cases in this sample was not reported).
However, in the only reported prospective study with a population diagnosed with major depression, Rush et al. (1986) found that patients' attributions for failure events did not predict their scores on the Beck Depression Inventory (BDI; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961 ) at a 6-month follow-up. Furthermore, the widely cited study of Lewinsohn and colleagues (Lewinsohn, Seinmetz, Larson, & Franklin, 1981) found no relationship between attributional style and future depression onset in a large community sample. Similarly, the only investigation of the interaction of attributional style and stressful life events in a clinical sample detected no significant interaction between attributional style and stressful events in the prediction of depression onset (Persons & Rao, 1985) . Therefore, there is only equivocal support for the hypothesized role of negative event attributions with respect to depression onset or relapse, although the hypothesis has not yet been adequately tested in a clinically depressed sample. Furthermore, no study has yet examined the role of positive event attributions with respect to relapse risk, although such attributions have been linked to recovery from dysphoric mood in two recent investigations (Edelman, Ahrens, & Haaga, 1994; Needles & Abramson, 1990) .
Axis II Personality Disorders and Depression Relapse
There are several reasons for hypothesizing that Axis II personality disorders may predispose individuals to the experience of depression (including depression relapse), for example, (a) Axis II disorders, by definition, engender "clinically significant distress" (American Psychiatric Association, 1994, p. 633); (b) Axis II disorders predispose individuals to the experience of negative life events (American Psychiatric Association, 1994; Pfohl, Coryell, Zimmerman, & Stangl, 1984) , which have been causally implicated in the onset of some depressive episodes (Brown & Harris, 1989) ; and (c) individuals with Axis II pathology tend to have very high levels of depressotypic cognitions (Evans & Craighead, 1995; O'Leary et al., 1991) .
There have been four empirical investigations of the relationship between Axis II personality pathology and depression relapse (Peselow, Fieve, & DiFiglia, 1992; Pfohl, Coryell, Zimmerman, & Stangl, 1987; Thompson, Gallagher, & Czirr, 1988; Zimmerman, Coryell, Pfohl, Corenthal, & Stangl, 1986) . These studies suggest that Axis II comorbidity confers an increased relapse risk after several forms of therapeutic intervention, including pharmacotherapy (Peselow et al., 1992; Pfohl et al., 1987) , electroconvulsive therapy (ECT; Zimmerman et al., 1986) , and short-term psychotherapy (Thompson et al., 1988) .
Two methodological caveats, however, are worth noting. First, none of the previous studies controlled for differences in posttreatment residual depression symptomatology that may exist between Axis II and non-Axis II patients. There is evidence that increased depression severity, especially at treatment termination, is a predictor of subsequent relapse (e.g., Shea et al.. 1992) ; therefore, to the extent that Axis II pathology is positively correlated with residual depression severity-as it was, for example, in the Pfohl et al. study-the reported relationship between Axis II pathology and depression relapse may be artifactual. It is also important to note that, with one exception (Thompson et al., 1988) , each of the aforementioned studies assessed depressed patients for Axis II pathology at pretreatment, that is, while patients were fully syndromal. However, a number of investigators have documented the potential bias inherent in personality assessment that occurs during a depressive episode, with depressed patients often reporting significantly higher levels of personality pathology than they do after achieving clinical remission (e.g., Stuart, Simons, Thase, & Pilkonis, 1992) . Therefore, it is possible that the observed relationship between Axis II pathology and depression relapse may be confounded, to some extent, by the assessment of personality at pretreatment. To address this possibility, the present investigation has included an assessment of Axis II pathology during a follow-up interview, at which time the majority of patients were no longer syndromal for major depression.
There is substantial evidence that dysfunctional cognitive patterns and Axis II personality disorders each comprise risk factors for depressive relapse. However, because Axis II pathology and dysfunctional cognitions appear to covary (Ilardi & Craighead, 1997; O'Leary et al., 1991) , it is quite possible that these two factors overlap considerably with respect to the prediction of depression relapse; that is, depressotypic cognitions and Axis II pathology may actually account for the same portion of the variance in relapse prevalence. No studies germane to this hypothesis have heretofore been reported. The present study, therefore, tests this hypothesis by including measures of depressotypic cognitions and Axis II pathology simultaneously in a survival-analytic model of depression relapse (Lavori, Keller, & Klerman, 1984) among 50 depressed inpatients. Because both pretreatment and follow-up measures of cognitive dysfunction were obtained for most participants in the study, this investigation also includes separate analyses for both pretreatment and follow-up measures in an effort to determine whether differences exist in the predictive power of these cognitive indices as a function of the time of assessment. In addition, the present study has controlled statistically for several variables that have been reported to contribute to the likelihood of depression relapse: residual depressive symptomatology at treatment termination (Sheaetal., 1992), so-called "double depression" (Coryell, Endicott, & Keller, 1991) , and number of prior depressive episodes (Keller et al., 1987) .
Method

Patient Selection
All patients included in the present investigation were inpatients on an affective disorders unit at the Duke University Medical Center. Study Loranger, Susman, Oldham, & Russakoff, 1987 ) was used to obtain information concerning the presence or absence of Axis II disorders for study participants. The PDE is a structured clinical interview that elicits information relevant to the diagnostic criteria associated with each of the 11 Axis n disorders enumerated under the DSM-III-R. PDE data were also used to construct it dimensional Axis II score for each patient; this score was computed as the sum of all criteria met for each of the 11 Axis II disorders. Followup PDE interviews for 10 study patients were evaluated by a second rater (an advanced psychology graduate student) for the purpose of assessing interrater reliability. An estimate of intraclass correlation (ICC) for PDE dimensional scores was calculated using Shrout and Fleiss's (1979) method for so-called Case 2 reliability models (Shrout & Fleiss, 1979, p. 423) . The resultant ICC (2,1) of .955 is indicative of very high interrater reliability.
Patients were assessed at follow-up using the Longitudinal Interval Follow-Up Evaluation (LIFE), a semistructured interview developed to assess the longitudinal course of psychiatric disorders (Keller et al., 1987) . Although the LIFE was originally designed for use over a 6-month follow-up period, it is capable of adaptation to "any length or number of follow-up intervals" (Keller et al., 1987, p. 540) . For the purposes of the present investigation, the LIFE interview was modified to query for any relapse or recurrence of affective disorder (including rehospitalization) throughout the 33-to 84-month follow-up period. Tb assess the interrrater reliability of the modified LIFE interview used in the present investigation, interviews for 8 study patients were observed and coded by a second rater (a first-year psychology graduate student).
Excellent reliability was achieved, with ICC (2,1) equal to .978. Furthermore, there was 100% agreement between raters regarding the presence or absence of major depressive episode at the time of the follow-up interview.
Weekly ratings of depression symptomatology were made during hospitalization by unit nursing staff using the Montgomery-Asberg Depression Rating Scale (MADRS; Montgomery &. Asberg, 1979) , which ranges in score from 0 to 60. Ratings were made on the basis of information obtained from interviews and patient observation. Nursing staff MADRS ratings have demonstrated good interrater reliability (Craighead et al., 1997) , with an estimated nurse-nurse ICC of .77 and nursephysician ICC of .60.
Questionnaires. Depressive cognitions associated with Beck's cognitive model (Beck, 1976) were assessed by means of the DAS (Form A; Weissman & Beck, 1978) , a 40-item self-report questionnaire. The DAS is designed to measure the presence of depressotypic underlying assumptions, or dysfunctional beliefs; it is the most widely used instrument for this purpose.
We assessed attributional style by means of the ASQ (Seligman et al., 1979) , which requires patients to "vividly imagine" 12 separate hypothetical events (6 positive and 6 negative events), and to make attributions about the occurrence of each event. The instrument yields separate composite subscale scores for positive and negative events (ASQ-Pand ASQ-N, respectively). The negative composite score represents the sum of "internal," "stable," and "global" subscales based on negative event items; likewise with the positive composite score and positive event items. Negative and positive composite scores, rather than individual ASQ subscale scores, were used because of the significantly higher reliability estimates associated with the composite measures (Sweeney, Anderson, & Bailey, 1986) . Both positive and negative ASQ composite scores were found to have satisfactory internal consistency in this patient sample, as evidenced by coefficient alphas (Cronbach, 1951) of .84 and .87, respectively.
Patients also completed the BDI (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) at the follow-up evaluation, which provided a selfreport, 21-item measure of current depressive symptomatology. The BDI is the most widely used self-report depression measure. Its reliability and validity as a measure of major depression severity have been demonstrated (Beck, Steer, & Garbin, 1988; Bamberry, Oliver, & McClure, 1978) .
Procedure
Hospitalization phase-assessment and treatment. All patients included in the present investigation were treated as inpatients on a 21-bed affective disorders unit at Duke University Medical Center. Routine clinical assessment methods completed during the first week of hospitalization include psychiatric and nursing interviews. In addition, patients were referred for psychological evaluation, which was completed in all cases during the first or second week of hospitalization; at the time of this evaluation, all patients met diagnostic criteria for major depression.
The evaluation included completion of the NIMH DIS; during the evaluation, 44 patients also completed the DAS, and 37 completed the ASQ.
Twenty-three of the 50 study patients were also evaluated for the pres-2 Demographic measures included age, gender, race, and marital status.
Clinical measures were as follows; number of prior depressive episodes, age of first depression onset, hospitalization discharge depression severity rating (on the Montgomery-Asberg Depression Rating Scale), Axis II comorbidity, and dysthymia comorbidity.
3 Twenty-three of the DIS Axis I interviews on study patients were conducted during index hospitalization under the auspices of the CRC/ PE for the Study of Depression, supported by Grant MH40159 from the National Institute of Mental Health to the Department of Psychiatry at Duke University, Durham, NC (principal investigator, Dan G. Blazer II). The relevant portions of the DIS interview for such patients were incorporated within the more extensive Duke Diagnostic Evaluation Schedule (DDES; see Blazer, Hughes, & George, 1992 , for a more detailed discussion). 4 For those 23 subjects who were interviewed as a result of their participation in the CRC study, Axis I diagnoses were made on the basis of case conference consensus (see Blazer et al., 1992) . For the other 27 patients, diagnoses were made by a clinical psychologist based on data obtained from the affective disorders portion of the DIS interview. 
Results
Sample Characteristics
Demographic and clinical characteristics of the patient sample are presented in Table 1 . Patients were grouped for presentation purposes according to Axis II diagnosis, as determined by the follow-up interview. As shown, Axis II and non-Axis II groups differed significantly with respect to age (M = 34.9 vs. 41.0, respectively), /(48) = 2.48, p < .05, and discharge MADRS rating (M = 18.3 vs. 10.9), *(48) = 3.74, p < .001. No other significant between-groups differences were observed. Table 2 displays summary statistics on self-report measures for the patient sample at follow-up. Axis II patients were observed to have significantly higher scores than non-Axis II patients on the follow-up BDI (M = 18.6 vs. 6.5), ( (48) 
Statistical Analyses
To explore the effect of personality pathology and depressotypic cognitions on the risk of relapse after recovery from depression, we used a series of survival-analytic models (see Cox, 1972; Cox & Oakes, 1984) . Such models are especially well suited to analyzing the effect of predictor variables on event probabilities in data sets with right-censoring (i.e., data in which 5 There were six additional study patients who were interviewed at the pre-treatment assessment with the Structured Interview for the DSM-/// Personality Disorders (SIDP; Stangl, Pfohl, Zimmerman, Bowers, & Corenthal, 1985) . However, because Axis II diagnoses derived from the SIDP are not fully compatible with those based on the PDE (inasmuch as the former uses DSM-III, and the latter DSM-Ill-R, criteria), it was decided to exclude data from these six SIDP interviews in any study analyses. 6 Patients also completed a visual analog mood scale (Luria, 1975) at follow-up. This instrument was used in a set of secondary analyses not reported herein. Note. BDI = Beck Depression Inventory; DAS = Dysfunctional Attitudes Scale; ASQ-N = Attributional Style Questionnaire composite subscale for negative events; ASQ-P = Attributional Style Questionnaire composite subscale for positive events.
• Axis n category based on follow-up interview. * Axis II group different from non-Axis II at p < .0001. ' Axis n group different from non-Axis II at p < .01. ' Axis n group different from non-Axis II at p < .05. ***p < .01.
1 or more patients has not experienced the target event-in this case, relapse-by the end of the observation period); thus, survival analysis is particularly appropriate for use with the type of longitudinal follow-up data reported in the present study (see Singer & Willett, 1991) . Accordingly, parametric accelerated "failure-tune" models were analyzed using SAS's LIFEREG procedure (SAS Institute, 1987) 
Depression Relapse: Survival Analyses
The baseline survival function for the 50 study patients is shown in Figure 1 . The survival function models the cumulative risk of relapse as a function of time since recovery. Although the distinction is frequently made between relapse and recurrence (see Frank et al., 1991) , with the former referring to the return of the full depressive syndrome after remission and the latter designating the occurrence of new episode after recovery 7 ,
for the purposes of the present investigation no such distinction is made: The term relapse is used to refer to the return of syndrome depression after a period of full or partial remission of at least 8 weeks' duration (see Spitzer, Endicott, & Robins, 1978) . As shown, the risk of relapse in this former inpatient sample was quite substantial; only 57% of the sample remained relapse-free at 6 months postrecovery, 45% remained relapsefree at 12 months, and 32% remained relapse-free at 24 months.
Sixteen study patients had not experienced a relapse by the time of follow-up assessment; that is, the model included 16 rightcensored failure-time values.
Because the number of prior depressive episodes, the presence of double depression (i.e., major depression and dysthymia), and depression severity rating at posttreatment have all been found by previous investigators to predict relapse risk, measures of these three variables (obtained at index hospitalization) were included as covariates. In addition, because the mean length of time between index hospitalization and follow-up (follow-up interval) was found to be significantly shorter for Axis II, compared with non-Axis II patients (p < .01) in this sample, the follow-up interval length was also included as a covariate in each survival model that used follow-up measures. Finally, the follow-up BDI score was added as a covariate as a means of controlling for the potentially confounding effect of depressive symptomatology at the time of the follow-up assessment, including dysphoric mood (Coyne, 1994) , which has been specifically linked to mood-congruent biases in recall of prior depressive episodes (Goodwin & Sher, 1993) at.the time of the followup assessment. The initial survival analysis included only the aforementioned five covariates as independent variables. Only the follow-up interval, likelihood ratio x 2 (l, N = 50) = 14.49, p < .0001; and BDI, likelihood ratio x 2 (l, N = 50) = 26.54, p < .0001, were found to be significantly predictive of relapse;
longer follow-up intervals were associated with decreased relapse risk, whereas BDI was related to increased risk. The num-7 Frank et al. (1991) , in a recent review, noted that the term recovery is usually applied to a remission that lasts for some prescribed duration; research diagnostic criteria (RDC; Spitzer, Endicott, & Robins, 1978) , for example, has denned recovery as a symptom-free period that lasts a minimum of 8 weeks. ber of prior episodes, posttreatment MADRS rating, and dysthymia comorbidity were not significantly predictive (p > .40). Accordingly, the latter three variables were omitted as covariates in subsequent survival models.
As shown in Table 3 , Models 1 through 7 used various follow- Note. For all chi-square values, the degree of freedom was 1. DAS = Dysfunctional Attitudes Scale; ASQ-N = Attributional Style Questionnaire composite subscale for negative events; ASQ-P = Attributional Style Questionnaire composite subscale for positive events. **p < .05. ***p < .01. ****;><.001.
up cognitive and Axis II measures as independent variables. All models included follow-up BDI score and follow-up interval length as covariates. Model 1 included follow-up DAS as the independent variable. The effect of DAS on relapse was not significant (p > .20). Model 2 included both attributional measures, ASQ-N and ASQ-P, as independent variables. Only ASQ-P (attribution for positive events) had a significant effect on relapse, likelihood ratio x 2 ( 1,^ = 44) = 10.73, p< .001, with a coefficient estimate of 0.057. Because of the nature of the log-linear model used in this analysis, each coefficient estimate may be transformed into a risk multiplier, which represents the proportional increase-decrease in expected survival time due to each unit increment for a given independent variable. The multiplier for ASQ-P score may, thus, be represented as e 0057 ,
which equals approximately 1.06; this indicates an approximate 6% cumulative increase in expected survival time for each incremental point on a patient's ASQ-P score. In order to understand the relative influence on expected survival time indicated by the aforementioned ASQ-P multiplier, it may be instructive to consider the effect of a 12-point increase (approximately 1 SD) in ASQ-P score: The resulting multiplier would be e 0057 " 2 , or 1.98, which would indicate an approximate doubling of expected survival time. Model 3 included the dimensional score of Axis II pathology as a lone independent variable. The coefficient estimate was -0.081, likelihood ratio x 2 (l, N = 50) = 39.80, p < .0001, with an indicated survival multiplier of 0.92. All three cognitive measures, in addition to the Axis II dimensional rating, were included simultaneously as independent variables in Model 4. Only the Axis II rating was significantly associated with relapse, likelihood ratio x 2 (l, N = 44) = 6.01, 
Prospective Analyses
Each of the aforementioned models used measures of Axis n pathology, DAS, ASQ-N, and ASQ-P obtained at the followup assessment, 33 to 78 months after the index hospitalization.
However, there were 44 study patients who completed the DAS and 37 who completed the ASQ during hospitalization (pretreatment); 23 patients also completed the PDE Axis fl interview at pretreatment. Although, as noted previously, the presence of the depressive episode may substantially bias assessment of these personality and cognitive constructs, use of such in-episode ratings provides a stronger prospective test of the effect of these constructs on subsequent risk of relapse. Accordingly, Models 1 -7 were each replicated using index hospitalization (in-episode ) measures of cognitive and Axis II measures (see Table 4 Note. For all chi-square values, the degree of freedom was 1. DAS = Dysfunctional Attitudes Scale; ASQ-N = Attributional Style Questionnaire composite subscale for negative events; ASQ-P = Attributional Style Questionnaire composite subscale for positive events.
• " = 44. <• n = 37. 
Discussion
Axis 11 Pathology and Depressive Relapse
This investigation's principal finding concerns the effect of Axis II personality pathology on depressive relapse. A dimensionalized measure of Axis II pathology (calculated as the total number of criteria met for all 11 Axis II disorders on the basis of the follow-up interview) was found to be significantly and substantially associated with relapse, with an approximate 8% cumulative decrease in expected remission duration for each Axis II criterion item met. In light of the strong association that has been observed between personality disorders and depressotypic cognitions (e.g., O'Leary et al., 1991) , we also decided to include measures of Axis II pathology, dysfunctional attitudes, and attributional style simultaneously in a survival model, as a means of determining the degree of relapse risk uniquely associated with each of these constructs. Disordered personality continued to exert a robust effect on relapse, regardless of whether such pathology was measured as a dimensional (Model 4) or categorical (Model 5) construct. While controlling for the effects of all cognitive measures and covariates, the survival model indicated that patients without a personality disorder have an expected survival (i.e., remission) period approximately 7.4 times longer than that of patients who met DSM-IH-R criteria for at least one Axis II disorder. The greatest risk disparity between Axis II and non-Axis fl patients was observed during the first 6 months after recovery, during which time 77% (17 of 22) of patients with personality disorders, but only 14% (4 of 28) of patients without personality disorders, had relapsed.
It is important to note that these survival models included each patient's follow-up BDI score as a covariate to control statistically for the potentially confounding influence of state depression 8 on both the reporting of Axis fl pathology (e.g., Stuart et al., 1992) and retrospective recall of relapse episodes (Goodwin & Sher, 1993) . Thus, the observed effect of Axis II pathology on relapse does not appear to be a mere artifact of differential depressive symptomatology among patients at the followup assessment.
Because the aforementioned models rely solely on follow-up (as opposed to prospective) measures, they do not permit an unequivocal interpretation of the observed relationship between Axis II and depressive relapse risk. There appear to be two distinct interpretations that could account for this study's finding: (a) Axis n pathology may have served as a genuine risk factor that rendered certain patients more vulnerable to the experience of depressive relapse, or (b) the occurrence of chronic or repeated episodes of depression over the follow-up period may have had a deleterious effect on the personality functioning of a subset of study patients, thereby causing them to report elevated levels of Axis II pathology at follow-up. To address the latter possibility, we conducted additional survival analyses (Models 10-14) using data obtained from that subset of study patients (46%) for whom truly prospective, in-episode interviews of Axis II pathology were available. Not only did Axis II pathology emerge as a significant predictor in these prospective models, but the estimated risk multiplier for the Axis II dimensional variable, calculated as an exponential function of survival model coefficients, remained relatively constant across assess-8 It remains to be clarified whether it is specifically the presence of syndromal depression or simply a dysphoric mood state that is primarily responsible for the artifacrual reporting bias frequently observed when assessment of personality or cognitive constructs is conducted while patients are depressed. Inasmuch as the BDI measures dysphoria (see Coyne, 1994) , as well as a host of cardinal depressive symptoms, inclusion of the BDT as a covariate in this investigation appears to control for both potential sources of reporting bias.
merit periods (Model 4 vs. Model 11). Specifically, expected patient survival time decreased by approximately 8% (compounded) for each additional Axis n criterion met, regardless of whether Axis II pathology was assessed during hospitalization or at follow-up. These prospective findings lend support to the aforemeritioned hypothesis that Axis II pathology substantially increases a patient's risk for the experience of subsequent relapse episodes. The differential effects of the three Axis D clusters with respect to relapse were also examined. Dimensional ratings of Clusters A, B, and C (on the basis of follow-up interviews) were entered simultaneously in a survival model; all three ratings were found to add significantly and independently to the relapse model. Intriguingly, however, only Cluster B and Cluster C pathology had a deleterious effect on relapse probability; increased Cluster A pathology was actually found to increase the likelihood of remaining relapse-free. This rather perplexing findingthat variance "unique" to Cluster A (i.e., controlling simultaneously for Clusters B and C) is associated with prolonged remission-is somewhat difficult to explain, although it may be noted that the three disorders that constitute Cluster A (schizoid, schizotypal, and paranoid) are each characterized by some degree of social detachment, a quality that may render such individuals less vulnerable to depressogenic social rejection experiences (Greenberg, Craighead, & Evans, 1996) .
Dysfunctional Cognitions and Depressive Relapse
This investigation also examined the effect on relapse of three cognitive constructs: dysfunctional attitudes, attributions for negative events, and attributions for positive events. Neither dysfunctional attitudes nor negative event attributions were found to be significantly associated with depressive relapse, regardless of whether in-episode or follow-up measures of these constructs were used. A significant and substantial effect, however, was observed for the follow-up positive attribution composite measure, ASQ-P. Specifically, the tendency to make internal, stable, and global attributions for positive events served as a type of "buffer" against depressive relapse, with a 6% cumulative increase in expected survival time for each 1-point increase in ASQ-P score; by extension, a \-SD increase in ASQ-P score indicated an approximate doubling of expected survival time. Furthermore, ASQ-P accounted for unique variance in the relapse model, beyond that accounted for by personality pathology. The prospective ASQ-P measure (assessed during patients' index hospitalization) did not appear to be as strongly associated with relapse, though its effect was found to be marginally significant.
Although the reformulated learned helplessness theory has hypothesized a preeminent role for negative event attributions in the onset of depression, the results of this investigation indicate that positive event attributions may, in fact, constitute a more important determinant of relapse risk. Such a finding appears to be somewhat consistent with a model of recovery from depression articulated by Needles and Abramson (1990) , which suggests that stable and global attributions for positive events may be central to the process of recovery from depressive affect (see Craighead, 1991; Edelman et al., 1994) . Thus, patients who engage in such positive event attributions might be especially resilient in the face of the subclinical dysphoric states that frequently occur subsequent to remission of the depressive syndrome. Because this study represents the first reported investigation of positive event attributions and depression relapse, it would be quite valuable to see a replication.
Methodological Considerations and Future Directions
The failure of both the pretreatment and follow-up DAS measures to exert a significant effect on relapse risk in this investigation stands in stark contrast to the findings of four previous studies (Rush et al., 1986; Segal et al., 1992; Simons et al., 1986; Thase et al., 1992) . The most obvious explanation for this discrepancy is the fact that these previous investigations all obtained DAS scores at posttreatment rather than at pretreatment or at follow-up. In fact, one might expect the continued presence of dysfunctional attitudes during the period immediately posttreatment to confer a greater relapse vulnerability than the presence of such dysfunctional cognitions either at pretreatment (when state depression serves as a notable confound) or at a follow-up several years posttreatment (by which time some dysfunctional attitudes may have changed). Thus, the present findings are not viewed as a strong disconfirmation of the hypothesized depressogenic role for dysfunctional attitudes. Nonetheless, because this is the only study of the DAS that has both controlled for depressive symptom severity at the time of DAS assessment and used DSM diagnostic criteria to determine patient relapse status, further investigation of the effect of posttreatment DAS on depressive relapse appears warranted. Because dysfunctional attitudes appear to be somewhat mood state dependent (i.e., there is evidence that they remain "latent" until they are pruned by the occurrence of a negatively valenced mood state; Miranda & Persons, 1988; Miranda, Persons, & Byers, 1990) , we believe that the optimal approach for future investigations would be to assess DAS immediately postremission but in tandem with some form of priming technique.
With a single exception-the dimensional rating of Axis n pathology-all cognitive and personality measures used in this investigation were more strongly associated with relapse when such measures were based on the follow-up, as opposed to the in-episode, assessment. This set of findings may perhaps best be explained as follows: (a) This study's personality assessments involved expert interviewers rather than self-report procedures and, as such, appear to have been less subject to possible artifactual mood-congruent reporting biases during the in-episode assessment than were the study's cognitive measures (Loranger, Lenzenwenger, Gartner, & Susman, 1991) ; and (b) the dimensional ratings of personality pathology were likely more robust than were categorical personality ratings to any trait-state artifacts that did exist, inasmuch as dimensional personality ratings appear to be more valid indicators of what are likely, in actuality, continuous latent variables (e.g., Trull, Widiger, & Guthrie, 1990) . Several limitations of this study are worth noting. First, data on the longitudinal course of posthospitalization depression symptomatology were obtained from a single follow-up interview that was rather far removed in time (33 to 84 months; M = 49.9 months) from the index hospitalization. This lengthy follow-up period undoubtedly also contributed to the substantial loss of potential study participants (36 of whom could not be tracked and 48 of whom declined participation 10 ); although there were no significant differences on demographic or pretreatment clinical measures between participants and nonparticipants, the existence of selection biases based on posttreatment patient characteristics cannot be ruled out. Furthermore, the structured interview used to obtain these data, the LIFE, was originally designed for use over a 6-month follow-up period (Keller et al., 1987) . Although its designers note that the LIFE is capable of adaptation to ' 'any length . . . of follow-up intervals" (Keller et al., 1987, p. 540) , it is reasonable to suspect that accuracy of patient recall of depressive symptomatology may be somewhat attenuated by the large time intervals used hi the present investigation; we are aware of no reported data with respect to the reliability and validity of LIFE interviews for major depression conducted beyond the recommended 6-month follow-up window. Accordingly, it would be valuable to see a replication of this study in which patients are assessed at regular 6-month intervals throughout the follow-up period. It should also be noted that the findings reported herein are based on a fairly small sample (n -50), which affords statistical power sufficient to detect only medium-to-large effects. Finally, although Axis n pathology emerged in this study as an important risk factor for depression relapse, the causal mechanisms by which personality disorders contribute to relapse risk remain unknown (see Ilardi & Craighead, 1994 . The Axis n effect on relapse was not related, in this investigation, to differential pharmacotherapy treatment over the follow-up period; indeed, 94% of all study patients continued to receive pharmacotherapy for at least 6 months postremission, and there were no observed differences in pharmacotherapy between Axis II and non-Axis II groups (it remains possible, of course, that medication compliance was lower among Axis II patients-such a hypothesis was not addressed by this investigation). It does seem likely, however, on the basis of the findings discussed herein, that personality pathology contributes to the risk of relapse by means of some mechanism beyond the operation of dysfunctional cognitive processes. In light of the very large effect of Axis n pathology on relapse risk observed in this investigation, elucidation of the specific mechanisms through which personality disorders engender depressive relapse would appear to constitute an important goal for subsequent research endeavors in this area.
